DJIA 17,776.91 93.33 0.53%
NASDAQ 4,997.46 5.52 0.11%
S&P 500 2,081.34 12.58 0.61%
market minute promo

Novo Nordisk (NYSE: NVO)

54.28 -0.50 (-0.91%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

NVO $54.28 -0.91%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $54.32
Previous Close $54.78
Daily Range $53.50 - $54.46
52-Week Range $41.72 - $58.21
Market Cap $143.8B
P/E Ratio 0.00
Dividend (Yield) $0.73 (1.0%)
Ex-Dividend Date
Dividend Pay Date
Volume 2,976,969
Average Daily Volume 1,307,252
Current FY EPS $1.85




Drug Makers

Novo Nordisk (NVO) Description

Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals. Website:

News & Commentary

Is This Novo Nordisk's Next Blockbuster Drug?

Novo recently presented terrific data on its pipeline drug IDegLira, but U.S. approval is still far from certain. If it can gain approval, will it be meaningful to the company?

Versartis (VSAR) Up on Partial Hold Lift on Lead Candidate - Analyst Blog

Arena - Belviq Sales Slide Again

Will Alder Alter The Way Migraines Are Treated?

Great Stocks From Around the World

Baxalta: A Spin-Off That Could Be Revalued Up To 50% Higher

Vivus- Qsymia Sales Dip And Flatten Out

Health Care Sector Update for 07/06/2015: ZSAN, MDCO, BITI

Nintai Returns: Q2 2015

Novartis' Cosentyx Positive in Psoriatic Arthritis Study - Analyst Blog

See More NVO News...

NVO's Top Competitors

NVO $54.28 (-0.91%)
Current stock: NVO
JNJ $98.92 (0.73%)
Current stock: JNJ
NVS $99.17 (0.56%)
Current stock: NVS
RHHBY $35.03 (-0.19%)
Current stock: RHHBY